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Abstract: Advanced degrees that combine a master’s in business with a master’s in biotechnology are 
popping up at a number of universities. The programs aim to churn out students who will bridge the gap 
between scientists and managers at biotech companies. This article explores these dual degrees, the 
students’ skills when they graduate and what they can do for the biotech industry.  
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Introduction 
Biotech industry experts have long lamented 
the gap between scientists and business managers 
at many companies. Academia who build start-ups 
based on their research discoveries often have no 
idea how to run a business. Managers often don’t 
fully understand the science behind their 
companies’ products [1]. Communication between 
the groups gets mired in the jargon of both fields.   
Government officials and industry executives 
have called for universities to produce students 
with both science and management expertise [2]. 
Students have also demanded an option for a dual 
degree. In response, schools are developing dual-
degree master’s programs that combine business 
and biotech. So far, the programs only accept a 
handful of students each year, but most say their 
rosters are growing. 
The first students to enroll in the programs are 
graduating now, and companies are hoping they 
will bring new and versatile talent to the biotech 
workforce. Local governments hope the students 
will boost budding biotech clusters and local 
economies.  
True, a few semesters of grad-level courses 
hardly makes a scientist out of businessperson, or 
a manager out of a researcher. And no textbook 
can teach the nuances of schmoozing necessary 
for making business deals. But the first recipients 
of these degrees are advancing their careers and 
building startups. Whether they could have done it 
without spending tens of thousands of dollars on 
advanced education, we may never know.   
 
The curriculum 
The purpose of almost any business-of-science 
program is to teach students to think beyond the 
academic world and to be more business-minded. 
Students should understand how to turn 
technology into products and to how to 
communicate complicated ideas to non-specialized 
audiences. But accomplishing this in the academic 
environment can be tough.  
 
University administrators say admitting the 
right students is the key. Applicants who are 
passionate about both business and science and 
who have somehow noticed the gap that exists 
between scientists and executives are the most 
promising.  
University of Pennsylvania initiated its dual 
degree program in 2003 after administrators 
noticed that many students in the business school 
were enrolling in biotech courses or getting second 
master’s in a science field, says Scott Diamond, 
director of Penn’s biotechnology program.  
But many people have talent in one area or the 
other, not both, say program directors. Others are 
not far enough along in their careers to realize the 
importance of having expertise in both areas. To 
sift through the applicants, some schools look for 
those with work experience and an undergraduate 
degree in science. For example, RMIT in 
Melbourne, Australia requires a degree in a science 
field and at least three years of industry work 
experience.  
Dual degrees can take anywhere from one to 
three years and up to more than 60 courses to 
complete, depending on the university. Most 
programs offer a part-time schedule for employed 
people who want to keep their jobs. 
The courses teach skills such as how to manage 
a team, patent a discovery, balance risk and 
network with investors. Students also spend time 
in the lab studying molecular biology and 
biochemistry.  
Some of the more interactive programs place 
students in internships. Others hire industry 
executives and investors as guest lecturers. The 
University of Calgary in Alberta, Canada brings in 
biotech experts every week to have lunch with the 
students [3].  
Interaction with local economies.  
When biotech executives and government 
officials complain about a weak talent pool of 
business-savvy scientists, they have their own 
businesses in mind [4]. And schools are listening to 
their grumblings. 
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Calgary gears its curriculum toward the needs 
of industry, says Derrick Rancourt, a coordinator 
of the university’s biotech program. “We thought 
it would strengthen the local economy if we 
created some expertise in the area,” he says.  
Recruiters often try to fill entry-level positions 
with graduates from nearby schools. Because they 
depend on these graduates, they sometimes help 
plan courses or create internships for them.  
The State University of New York in its 
Brooklyn location hosts a biotech incubator where 
fledgling companies—most of which were started 
by the school’s faculty—rent space for their start-
ups. Some of the companies offer internships for 
students at the university. 
Many programs are geared for part-time 
students working locally who want to switch from 
the bench to management or seek a promotion. 
Other programs focus on entrepreneurship and 
help students build starts-ups headquartered locally 
and elsewhere. 
Countries and cities with an entrepreneurial 
culture will likely produce more business-minded 
scientists, says O. Prem Das, director of 
technology development at Harvard Medical 
School. Australia, a country that strongly values 
entrepreneurship, is home to a significant portion 
of universities that offer either a dual degree or 
some kind of business component in their biotech 
programs.  
Cities known for their biotech clusters can also 
generate interest in the field. For example, the 
University of California hosts its biotech 
entrepreneurship program in San Francisco, one of 
the largest biotech clusters in the world.  
 
Will the programs fill the void? 
 
When students graduate from dual degree 
programs, they want to have acquired a business 
sense that matches their lab expertise, along with 
contacts in the industry. But can academics teach 
students not to be so, well, academic? 
Time devoted to education allows 
entrepreneurs to slow down and take a few years 
to observe the field. School allows them to take 
the time to make thoughtful decisions on who they 
want to work with and which technologies to 
pursue.  
But clearly, a few courses in basic science can’t 
replace the bench experience aspiring researchers 
would receive in a post doctoral position. 
Likewise, class time could never rival experience 
gained through personal relationships with people 
in the business.   
True, some universities are making efforts to 
connect students to investors, intellectual property 
lawyers and executives. What these introductions 
accomplish is difficult to measure.  
Students who build start-ups using the investors 
they met in school are evidence of success. But no 
amount of networking or lab time will mold 
students to love the business of science. A student 
must have the entrepreneurial bug—or at least a 
knack for managing—to translate an idea into a 
product.  
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